Inhibitors of Hepatitis B Virus Covalently Closed Circular DNA Formation and Their Method of Use

摘要

Pharmaceutical compositions of the invention comprise covalently closed circular DNA formation inhibitors having a disease-modifying action in the treatment of diseases associated with the formation of covalently closed circular DNA that include hepatitis B infection, and any disease involving formation of covalently closed circular DNA.